David Deperthes

There’s a veritable revolution underway in the field of medical diagnosis, and GenePOC is at its forefront. This growing company is looking for professionals to expand its team! Interested in the field of medicine? Passionate about microbiology and molecular biology? Join our team and become an integral part of an adventure that will change the way infectious diseases are diagnosed. To learn more about the current open positions, click here: http://bit.ly/1CVx1Tc GenePOC is a privately-owned Quebec company founded by Dr. Michel G. Bergeron. It specializes in the development and commercialisation of rapid molecular assays usable on the unique revogene platform for near patient infectious disease diagnostic. The revogene system improves working conditions for healthcare professionals and speeds up the diagnostic process. In approximately one hour or less, GenePOC can establish the presence of an infection that could have a serious impact on a person’s life. This is a significant improvement in health care. Our team of experienced professionals is dedicated to provide to the healthcare community fast and high-quality diagnostic tools helping them to choose the appropriate treatment for infectious diseases and offer better care for patients around the world. The revogene technology has been recognized by the scientific community with a number of awards, including the Frost & Sullivan 2017 Disruptive Innovator Award and Red Dot 2017 Award with “the best of the best” recognizing revogene design.

Small biotech company which develop treatments for important dermatology disorders mainly based on kallikrein and protease targeting

There’s a veritable revolution underway in the field of medical diagnosis, and GenePOC is at its forefront. This growing company is looking for professionals to expand its team! Interested in the field of medicine? Passionate about microbiology and molecular biology? Join our team and become an integral part of an adventure that will change the way infectious diseases are diagnosed. To learn more about the current open positions, click here: http://bit.ly/1CVx1Tc GenePOC is a privately-owned Quebec company founded by Dr. Michel G. Bergeron. It specializes in the development and commercialisation of rapid molecular assays usable on the unique revogene platform for near patient infectious disease diagnostic. The revogene system improves working conditions for healthcare professionals and speeds up the diagnostic process. In approximately one hour or less, GenePOC can establish the presence of an infection that could have a serious impact on a person’s life. This is a significant improvement in health care. Our team of experienced professionals is dedicated to provide to the healthcare community fast and high-quality diagnostic tools helping them to choose the appropriate treatment for infectious diseases and offer better care for patients around the world. The revogene technology has been recognized by the scientific community with a number of awards, including the Frost & Sullivan 2017 Disruptive Innovator Award and Red Dot 2017 Award with “the best of the best” recognizing revogene design.

Small biotech company which develop treatments for important dermatology disorders mainly based on kallikrein and protease targeting

Small biotech company which develop treatments for important dermatology disorders mainly based on kallikrein and protease targeting